Sleeping Aids Market Share, Size, Trends, Industry Analysis Report, By Product (Mattresses & Pillows, Sleep Laboratories, Medications, Sleep Apnea Devices); By Sleep Disorders; By Region; Segment Forecast, 2022 - 2030

Sleeping Aids Market Share, Size, Trends, Industry Analysis Report, By Product (Mattresses & Pillows, Sleep Laboratories, Medications, Sleep Apnea Devices); By Sleep Disorders; By Region; Segment Forecast, 2022 - 2030

The global sleeping aids market size is expected t-reach USD 118.31 billion by 2030 according t-a new study by Polaris Market Research. The report “Sleeping Aids Market Share, Size, Trends, Industry Analysis Report, By Product (Mattresses & Pillows, Sleep Laboratories, Medications, Sleep Apnea Devices); By Sleep Disorders; By Region; Segment Forecast, 2022 – 2030” gives a detailed insight int-current market dynamics and provides analysis on future market growth.

The growing number of patient base suffering from respiratory issues, cardiovascular illnesses, and Obstructive Sleep Apnea (OSA), coupled with the rising occurrence of insomnia, are the primary factors that are likely t-accelerate the industry demand across the globe. In addition, growing awareness regarding the accessibility of various sleeping aids and rising investments by the companies in the R&D activities are bolstering the industry growth across the globe. Moreover, factors such as rising consumption of alcohol and tobacco, sedentary lifestyle, stressful working hours are further attributed t-the global industry demand in the forecasting years.

Based on the sleep disorders, the insomnia segment is dominating the global industry with the highest revenue shares owing t-the irregular sleep schedule, stress, poor sleeping habits, and many others, coupled with the rising incidences of these disorders among the young and millennial population may lead t-the segment demand. Whereas the sleep apnea segment is showing the highest CAGR rate that leads the industry demand. Factors such as the growing prevalence of patients affected with OSA (Obstructive Sleep Apnea), and growing awareness regarding the availability of various pills are fostering the global demand in the approaching years.

The growing prevalence of sleep apnea and insomnia among the population is a major health problem, which acts as a major driving factor for the industry’s growth. For instance, as per the Sleep Foundation, nearly 10% t-30% of adults and 30% t-48% of older adults are suffering from insomnia. Additionally, narcolepsy is als-an erratic disorder that can be treated and controlled with the help of sleep aids. Consequently, lack of sleep is decreasing productivity causes stress, depression, physical illnesses and pain, medications, and other neurological problems. Therefore, the industry is gaining huge traction among the population t-cure their sleep disorders. Additionally, advancements in the types of sleeping aids such as mattresses and pillows are als-propelling the global demand in the near future.

Market participants such as Natus Medical Incorporated, Biodiem, Cadwell Industries Inc., Compumedics Limited, CSL Limited, Devilbiss Healthcare, Drive, Emergent Biosolutions, F.Hoffmann-La Roche Ltd., Sleepmed Inc., Gamma Vaccines Pty Ltd., GlaxoSmithKline Plc, Koninklijke Philips N.V., Merck & Co., Inc., AstraZeneca Plc, Pfizer Inc., Sanofi, Sinovac Biotech Ltd., and Novartis AG are some of the key players operating in the global industry.

The frequent tactical movements such as mergers & acquisitions, product developments & launches, and others by the prominent industry players are supporting the global market development. For instance, in April 2021, Sandland Sleep introduced a new product, cannabinoid CBN-a, a natural, hemp-derived ingredient.

Polaris Market Research has segmented the sleeping aids market report on the basis of product, sleep disorder, and region:

Sleeping Aids, Product Outlook (Revenue – USD Billion, 2018 – 2030)

  • Mattresses & Pillows
  • Sleep Laboratories
  • Medications
    • Prescription-based Drugs
      OTC drugs
      Herbal drugs
  • Sleep Apnea Devices
Sleeping Aids, Sleep Disorders Outlook (Revenue – USD Billion, 2018 – 2030)
  • Insomnia
  • Sleep Apnea
  • Restless Legs Syndrome
  • Narcolepsy
  • Sleep Walking
  • Others
Sleeping Aids, Regional Outlook (Revenue – USD Billion, 2018 – 2030)
  • North America
  • U.S.
  • Canada
  • Europe
  • France
  • Germany
  • UK
  • Italy
  • Spain
  • Netherlands
  • Austria
  • Asia Pacific
  • China
  • India
  • Japan
  • Malaysia
  • South Korea
  • Indonesia
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa


1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
2.1. Market Highlights
3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources
4. Sleeping Aids Market Insights
4.1. Sleeping Aids Market – Industry Snapshot
4.2. Sleeping Aids Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. The surge in cases of sleep disorders with changing lifestyle
4.2.1.2. Technological advancements
4.2.2. Restraints and Challenges
4.2.2.1. High cost of devices
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTLE Analysis
4.5. Sleeping Aids Industry trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis
5. Global Sleeping Aids Market, by Product
5.1. Key Findings
5.2. Introduction
5.2.1. Global Sleeping Aids, by Product, 2018 - 2030 (USD Billion)
5.3. Mattresses & Pillows
5.3.1. Global Sleeping Aids Market, by Mattresses & Pillows, by Region, 2018 - 2030 (USD Billion)
5.4. Sleep Laboratories
5.4.1. Global Sleeping Aids Market, by Sleep Laboratories, by Region, 2018 - 2030 (USD Billion)
5.5. Medications
5.5.1. Global Sleeping Aids Market, by Medications, by Region, 2018 - 2030 (USD Billion)
5.5.2. Prescription-based Drugs
5.5.2.1. Global Sleeping Aids Market, by Prescription-based Drugs, by Region, 2018 - 2030 (USD Billion)
5.5.3. OTC drugs
5.5.3.1. Global Sleeping Aids Market, by OTC drugs, by Region, 2018 - 2030 (USD Billion)
5.5.4. Herbal drugs
5.5.4.1. Global Sleeping Aids Market, by Herbal drugs, by Region, 2018 - 2030 (USD Billion)
5.6. Sleep Apnea Devices
5.6.1. Global Sleeping Aids Market, by Sleep Apnea Devices, by Region, 2018 - 2030 (USD Billion)
6. Global Sleeping Aids Market, by Sleep Disorders
6.1. Key Findings
6.2. Introduction
6.2.1. Global Sleeping Aids Market, by Sleep Disorders, 2018 - 2030 (USD Billion)
6.3. Insomnia
6.3.1. Global Sleeping Aids Market, by Insomnia, by Region, 2018 - 2030 (USD Billion)
6.4. Sleep Apnea
6.4.1. Global Sleeping Aids Market, by Sleep Apnea, by Region, 2018 - 2030 (USD Billion)
6.5. Restless Legs Syndrome
6.5.1. Global Sleeping Aids Market, by Restless Legs Syndrome, by Region, 2018 - 2030 (USD Billion)
6.6. Narcolepsy
6.6.1. Global Sleeping Aids Market, by Narcolepsy, by Region, 2018 - 2030 (USD Billion)
6.7. Sleep Walking
6.7.1. Global Sleeping Aids Market, by Sleep Walking, by Region, 2018 - 2030 (USD Billion)
6.8. Others
6.8.1. Global Other Sleeping Aids Market, by Sleep Apnea, by Region, 2018 - 2030 (USD Billion)
7. Global Sleeping Aids Market, by Geography
7.1. Key findings
7.2. Introduction
7.2.1. Sleeping Aids Market Assessment, By Geography, 2018 - 2030 (USD Billion)
7.3. Sleeping Aids Market – North America
7.3.1. North America: Sleeping Aids Market, by Sleep Disorders, 2018 - 2030 (USD Billion)
7.3.2. North America: Sleeping Aids Market, by Product, 2018 - 2030 (USD Billion)
7.3.3. Sleeping Aids Market – U.S.
7.3.3.1. U.S.: Sleeping Aids Market, by Sleep Disorders, 2018 - 2030 (USD Billion)
7.3.3.2. U.S.: Sleeping Aids Market, by Product, 2018 - 2030 (USD Billion)
7.3.4. Sleeping Aids Market – Canada
7.3.4.1. Canada: Sleeping Aids Market, by Sleep Disorders, 2018 - 2030 (USD Billion)
7.3.4.2. Canada: Sleeping Aids Market, by Product, 2018 - 2030 (USD Billion)
7.4. Sleeping Aids Market – Europe
7.4.1. Europe: Sleeping Aids Market, by Sleep Disorders, 2018 - 2030 (USD Billion)
7.4.2. Europe: Sleeping Aids Market, by Product, 2018 - 2030 (USD Billion)
7.4.3. Sleeping Aids Market – UK
7.4.3.1. UK: Sleeping Aids Market, by Sleep Disorders, 2018 - 2030 (USD Billion)
7.4.3.2. UK: Sleeping Aids Market, by Product, 2018 - 2030 (USD Billion)
7.4.4. Sleeping Aids Market – France
7.4.4.1. France: Sleeping Aids Market, by Sleep Disorders, 2018 - 2030 (USD Billion)
7.4.4.2. France: Sleeping Aids Market, by Product, 2018 - 2030 (USD Billion)
7.4.5. Sleeping Aids Market – Germany
7.4.5.1. Germany: Sleeping Aids Market, by Sleep Disorders, 2018 - 2030 (USD Billion)
7.4.5.2. Germany: Sleeping Aids Market, by Product, 2018 - 2030 (USD Billion)
7.4.6. Sleeping Aids Market – Italy
7.4.6.1. Italy: Sleeping Aids Market, by Sleep Disorders, 2018 - 2030 (USD Billion)
7.4.6.2. Italy: Sleeping Aids Market, by Product, 2018 - 2030 (USD Billion)
7.4.7. Sleeping Aids Market – Spain
7.4.7.1. Spain: Sleeping Aids Market, by Sleep Disorders, 2018 - 2030 (USD Billion)
7.4.7.2. Spain: Sleeping Aids Market, by Product, 2018 - 2030 (USD Billion)
7.4.8. Sleeping Aids Market – Netherlands
7.4.8.1. Netherlands: Sleeping Aids Market, by Sleep Disorders, 2018 - 2030 (USD Billion)
7.4.8.2. Netherlands: Sleeping Aids Market, by Product, 2018 - 2030 (USD Billion)
7.4.9. Sleeping Aids Market – Austria
7.4.9.1. Austria: Sleeping Aids Market, by Sleep Disorders, 2018 - 2030 (USD Billion)
7.4.9.2. Austria: Sleeping Aids Market, by Product, 2018 - 2030 (USD Billion)
7.5. Sleeping Aids Market – Asia Pacific
7.5.1. Asia Pacific: Sleeping Aids Market, by Sleep Disorders, 2018 - 2030 (USD Billion)
7.5.2. Asia Pacific: Sleeping Aids Market, by Product, 2018 - 2030 (USD Billion)
7.5.3. Sleeping Aids Market – China
7.5.3.1. China: Sleeping Aids Market, by Sleep Disorders, 2018 - 2030 (USD Billion)
7.5.3.2. China: Sleeping Aids Market, by Product, 2018 - 2030 (USD Billion)
7.5.4. Sleeping Aids Market – India
7.5.4.1. India: Sleeping Aids Market, by Sleep Disorders, 2018 - 2030 (USD Billion)
7.5.4.2. India: Sleeping Aids Market, by Product, 2018 - 2030 (USD Billion)
7.5.5. Sleeping Aids Market – Malaysia
7.5.5.1. Malaysia: Sleeping Aids Market, by Sleep Disorders, 2018 - 2030 (USD Billion)
7.5.5.2. Malaysia: Sleeping Aids Market, by Product, 2018 - 2030 (USD Billion)
7.5.6. Sleeping Aids Market – Japan
7.5.6.1. Japan: Sleeping Aids Market, by Sleep Disorders, 2018 - 2030 (USD Billion)
7.5.6.2. Japan: Sleeping Aids Market, by Product, 2018 - 2030 (USD Billion)
7.5.7. Sleeping Aids Market – Indonesia
7.5.7.1. Indonesia: Sleeping Aids Market, by Sleep Disorders, 2018 - 2030 (USD Billion)
7.5.7.2. Indonesia: Sleeping Aids Market, by Product, 2018 - 2030 (USD Billion)
7.5.8. Sleeping Aids Market – South Korea
7.5.8.1. South Korea: Sleeping Aids Market, by Sleep Disorders, 2018 - 2030 (USD Billion)
7.5.8.2. South Korea: Sleeping Aids Market, by Product, 2018 - 2030 (USD Billion)
7.6. Sleeping Aids Market – Middle East & Africa
7.6.1. Middle East & Africa: Sleeping Aids Market, by Sleep Disorders, 2018 - 2030 (USD Billion)
7.6.2. Middle East & Africa: Sleeping Aids Market, by Product, 2018 - 2030 (USD Billion)
7.6.3. Sleeping Aids Market – Saudi Arabia
7.6.3.1. Saudi Arabia: Sleeping Aids Market, by Sleep Disorders, 2018 - 2030 (USD Billion)
7.6.3.2. Saudi Arabia: Sleeping Aids Market, by Product, 2018 - 2030 (USD Billion)
7.6.4. Sleeping Aids Market – UAE
7.6.4.1. UAE: Sleeping Aids Market, by Sleep Disorders, 2018 - 2030 (USD Billion)
7.6.4.2. UAE: Sleeping Aids Market, by Product, 2018 - 2030 (USD Billion)
7.6.5. Sleeping Aids Market – Israel
7.6.5.1. Israel: Sleeping Aids Market, by Sleep Disorders, 2018 - 2030 (USD Billion)
7.6.5.2. Israel: Sleeping Aids Market, by Product, 2018 - 2030 (USD Billion)
7.6.6. Sleeping Aids Market – South Africa
7.6.6.1. South Africa: Sleeping Aids Market, by Sleep Disorders, 2018 - 2030 (USD Billion)
7.6.6.2. South Africa: Sleeping Aids Market, by Product, 2018 - 2030 (USD Billion)
7.7. Sleeping Aids Market – Latin America
7.7.1. Latin America: Sleeping Aids Market, by Sleep Disorders, 2018 - 2030 (USD Billion)
7.7.2. Latin America: Sleeping Aids Market, by Product, 2018 - 2030 (USD Billion)
7.7.3. Sleeping Aids Market – Mexico
7.7.3.1. Mexico: Sleeping Aids Market, by Sleep Disorders, 2018 - 2030 (USD Billion)
7.7.3.2. Mexico: Sleeping Aids Market, by Product, 2018 - 2030 (USD Billion)
7.7.4. Sleeping Aids Market – Brazil
7.7.4.1. Brazil: Sleeping Aids Market, by Sleep Disorders, 2018 - 2030 (USD Billion)
7.7.4.2. Brazil: Sleeping Aids Market, by Product, 2018 - 2030 (USD Billion)
7.7.5. Sleeping Aids Market – Argentina
7.7.5.1. Argentina: Sleeping Aids Market, by Sleep Disorders, 2018 - 2030 (USD Billion)
7.7.5.2. Argentina: Sleeping Aids Market, by Product, 2018 - 2030 (USD Billion)
8. Competitive Landscape
8.1. Expansion and Acquisition Analysis
8.1.1. Expansion
8.1.2. Acquisitions
8.2. Partnerships/Collaborations/Agreements/Exhibitions
9. Company Profiles
9.1. Astrazeneca Plc
9.1.1. Company Overview
9.1.2. Financial Performance
9.1.3. Product Benchmarking
9.1.4. Recent Development
9.2. Biodiem
9.2.1. Company Overview
9.2.2. Financial Performance
9.2.3. Product Benchmarking
9.2.4. Recent Development
9.3. Cadwell Industries Inc.
9.3.1. Company Overview
9.3.2. Financial Performance
9.3.3. Product Benchmarking
9.3.4. Recent Development
9.4. Compumedics Limited
9.4.1. Company Overview
9.4.2. Financial Performance
9.4.3. Product Benchmarking
9.4.4. Recent Development
9.5. CSL Limited
9.5.1. Company Overview
9.5.2. Financial Performance
9.5.3. Product Benchmarking
9.5.4. Recent Development
9.6. Drive
9.6.1. Company Overview
9.6.2. Financial Performance
9.6.3. Product Benchmarking
9.6.4. Recent Development
9.7. Devilbiss Healthcare
9.7.1. Company Overview
9.7.2. Financial Performance
9.7.3. Product Benchmarking
9.7.4. Recent Development
9.8. Emergent Biosolutions
9.8.1. Company Overview
9.8.2. Financial Performance
9.8.3. Product Benchmarking
9.8.4. Recent Development
9.9. F.Hoffmann-La Roche Ltd
9.9.1. Company Overview
9.9.2. Financial Performance
9.9.3. Product Benchmarking
9.9.4. Recent Development
9.10. Gamma Vaccines Pty Ltd
9.10.1. Company Overview
9.10.2. Financial Performance
9.10.3. Product Benchmarking
9.10.4. Recent Development
9.11. GlaxoSmithKline Plc
9.11.1. Company Overview
9.11.2. Financial Performance
9.11.3. Product Benchmarking
9.11.4. Recent Development
9.12. Koninklijke Philips N.V.
9.12.1. Company Overview
9.12.2. Financial Performance
9.12.3. Product Benchmarking
9.12.4. Recent Development
9.13. Merck & Co., Inc.
9.13.1. Company Overview
9.13.2. Financial Performance
9.13.3. Product Benchmarking
9.13.4. Recent Development
9.14. Natus Medical Incorporated
9.14.1. Company Overview
9.14.2. Financial Performance
9.14.3. Product Benchmarking
9.14.4. Recent Development
9.15. Novartis AG
9.15.1. Company Overview
9.15.2. Financial Performance
9.15.3. Product Benchmarking
9.15.4. Recent Development
9.16. Pfizer Inc.
9.16.1. Company Overview
9.16.2. Financial Performance
9.16.3. Product Benchmarking
9.16.4. Recent Development
9.17. Sanofi
9.17.1. Company Overview
9.17.2. Financial Performance
9.17.3. Product Benchmarking
9.17.4. Recent Development
9.18. Sinovac Biotech Ltd
9.18.1. Company Overview
9.18.2. Financial Performance
9.18.3. Product Benchmarking
9.18.4. Recent Development
9.19. Sleepmed Inc.
9.19.1. Company Overview
9.19.2. Financial Performance
9.19.3. Product Benchmarking
9.19.4. Recent Development

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings